Core Insights - Ardent Health, Inc. is under investigation for potential violations of federal securities laws due to improper accounting practices related to accounts receivable and professional liability reserves [1][2]. Financial Performance - In Q3 2025, Ardent reported a $43 million decrease in revenue after conducting evaluations of historical collection trends [3]. - The company also increased its professional liability reserves by $54 million due to adverse developments from claims made between 2019 and 2022, as well as broader industry trends [3]. - Following the financial disclosures, Ardent's stock price dropped over 33% during trading on November 13, 2025 [3]. Legal Context - Bleichmar Fonti & Auld LLP is leading the investigation and encourages affected investors to seek additional information regarding potential legal options [1][4]. - The law firm operates on a contingency fee basis, meaning shareholders are not responsible for court costs or litigation expenses [4]. Company Overview - Ardent Health operates a network of hospitals, ambulatory facilities, and physician practices primarily in mid-sized urban communities across the U.S. [2].
ARDT SHAREHOLDERS: A Securities Investigation into Ardent Health, Inc. has been Initiated on behalf of Investors -- Contact BFA Law if You Suffered Losses